The Breast Cancer Research Foundation of Alabama is proud to support innovative breast cancer research through the O’Neal Invests Award Grants and O’Neal NextGen Scholar Awards at the O'Neal Cancer…
The Breast Cancer Research Foundation of Alabama (BCRFA) announces a continued commitment to advancing breast cancer research in 2025 with an impressive $1,200,000 investment.
The Breast Cancer Research Foundation of Alabama (BCRFA) enthusiastically announces its continued dedication to support breast cancer research in Alabama through a significant investment of $1,125,000 in 2024.
Dr. Laura Rogers, Professor in the Division of Preventive Medicine, Department of Medicine at the University of Alabama at Birmingham (UAB), received support awarded in 2021-2022 for her research in exercise, gut microbiome,…
The BCRFA is pleased to announce funding for three pre-RO1 breast cancer projects at the O’Neal Comprehensive Cancer Center at UAB. Grantees will receive $160,000 over two years.
The BCRFA today announced its investment of $1.25M to power breast cancer research across Alabama. From breakthroughs in early detection to prevention treatments, these grants will fund 35 innovative projects at 8 partner institutes and ultimately help save lives.
The BCRFA recently announced funding for a groundbreaking project led by Dr. Steve Lim at the University of Alabama at Birmingham (UAB) to combat Triple Negative Breast Cancer (TNBC). Dr. Lim's research investigates Focal Adhesion Kinase (FAK) and its role in TNBC, exploring combination therapies that enhance estrogen signals for improved treatment outcomes.
In recent years, the BCRFA provided grant support for the earlier stages of this work, allowing Ponnazhagan to collect the large amounts of preliminary data required to apply to national funders.
Dr. Shevde-Samant’s goal is to learn more about how obesity and high blood sugar levels can affect breast cancer and potentially find new ways to treat it. This is especially relevant for Alabama, a state where over 15% of adults have diabetes, and of these 80% are overweight-to-obese.
